Cargando…

Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study

BACKGROUND: Research suggests the protection offered by COVID-19 vaccines might wane over time, prompting consideration of booster vaccinations. Data on which vaccines offer the most robust protection over time, and which patients are most vulnerable to attenuating protection, could help inform pote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wright, Bill J, Tideman, Samuel, Diaz, George A, French, Thomas, Parsons, Guilford T, Robicsek, Ari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881000/ https://www.ncbi.nlm.nih.gov/pubmed/35227415 http://dx.doi.org/10.1016/S2213-2600(22)00042-X

Ejemplares similares

Decreased Risk of Coronavirus Disease 2019–Related Hospitalization Associated With the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2
por: Ridgway, Jessica P, et al.
Publicado: (2022)

Rates of COVID-19 Among Unvaccinated Adults With Prior COVID-19
por: Ridgway, Jessica P., et al.
Publicado: (2022)

Patient-Reported Outcomes for Fully Vaccinated COVID-19 Patients Over 6 Weeks: The Experiences of Clinical Breakthrough Cases
por: Vartanian, Keri, et al.
Publicado: (2022)

Integrating patient-reported physical, mental, and social impacts to classify long COVID experiences
por: Vartanian, Keri, et al.
Publicado: (2023)

Surge effects and survival to hospital discharge in critical care patients with COVID-19 during the early pandemic: a cohort study
por: Dale, Christopher R., et al.
Publicado: (2021)

Prolonged shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) RNA among patients with coronavirus disease 2019 (COVID-19)
por: Ridgway, Jessica P., et al.
Publicado: (2020)

Clinical Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Tests for Diagnosing Coronavirus Disease 2019
por: Ridgway, Jessica P, et al.
Publicado: (2020)

Risk of coronavirus disease 2019 (COVID-19) acquisition among emergency department patients: A retrospective case control study
por: Ridgway, Jessica P., et al.
Publicado: (2020)

Compromise or Capitulation? US Food and Drug Administration Jurisdiction Over Tobacco Products
por: Glantz, Stanton A., et al.
Publicado: (2009)

Active Surveillance and Decolonization Without Isolation Is Effective in Preventing Methicillin-Resistant Staphylococcus aureus Transmission in the Psychiatry Units
por: Das, Sanchita, et al.
Publicado: (2014)

Over to us
Publicado: (1971)

Vaccines, pharmaceutical products, and bioterrorism: challenges for the U.S. Food and Drug Administration.
por: Zoon, K C
Publicado: (1999)

Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
por: Cromer, Deborah, et al.
Publicado: (2023)

The Route of Administration of Rabies Vaccines: Comparing the Data
por: Briggs, Deborah J., et al.
Publicado: (2021)

Methicillin-resistant staphylococcus aureus nosocomial infection has a distinct epidemiological position and acts as a marker for overall hospital-acquired infection trends
por: Samia, Noelle I., et al.
Publicado: (2022)

Cancer prevalence among flight attendants compared to the general population
por: McNeely, Eileen, et al.
Publicado: (2018)

Documenting Penicillin Allergy: The Impact of Inconsistency
por: Shah, Nirav S., et al.
Publicado: (2016)

Estimating the health consequences of flight attendant work: comparing flight attendant health to the general population in a cross-sectional study
por: McNeely, Eileen, et al.
Publicado: (2018)

The US Food and Drug Administration's tentative approval process and the global fight against HIV
por: Chahal, Harinder Singh, et al.
Publicado: (2017)

The US Food and Drug Administration Provides a Pathway for Licensing Vaccines for Global Diseases
por: Brennan, Michael J.
Publicado: (2009)

Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020
por: Moneer, Osman, et al.
Publicado: (2021)

888 Performance Characteristics and Associated Outcomes for an Automated Surveillance Tool for Blood Stream Infection
por: Ridgway, Jessica P., et al.
Publicado: (2014)

Vaccine hesitancy against COVID-19 vaccine over time in Nigeria
por: Sato, Ryoko
Publicado: (2023)

Microbiota and Its Role on Viral Evasion: Is It With Us or Against Us?
por: Domínguez-Díaz, Carolina, et al.
Publicado: (2019)

The association between US Food and Drug Administration−expedited review designations and health plan specialty drug coverage
por: Panzer, Ari D, et al.
Publicado: (2023)

Changes over Time in COVID-19 Vaccination Inequalities in Eight Large U.S. Cities
por: Michael Gaddis, S., et al.
Publicado: (2023)

U.S. Health Resources & Services Administration
por: Washko, Michelle M.
Publicado: (2022)

Maya ceramic vases from the classic period : the November collection of Maya ceramics /
por: Robicsek, Francis
Publicado: (1982)

Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration
por: Egilman, Alexander, et al.
Publicado: (2021)

Willingness to Vaccinate Against COVID-19: Predictors of Vaccine Uptake Among Adults in the US
por: Burch, Ashley E., et al.
Publicado: (2021)

US trends in premature heart disease mortality over the past 50 years: Where do we go from here?
por: Ritchey, Matthew D., et al.
Publicado: (2019)

Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US
por: Peasah, Samuel K., et al.
Publicado: (2019)

The Association between Proton Pump Inhibitors and Myocardial Infarction: What Do Food and Drug Administration Data Tell Us?
por: Tan, Jiun Ming, et al.
Publicado: (2019)

Comparative effectiveness and durability of COVID‐19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign
por: Lytras, Theodore, et al.
Publicado: (2022)

Association Between State-Issued COVID-19 Vaccine Mandates and Vaccine Administration Rates in 12 US States and the District of Columbia
por: Howard-Williams, Mara, et al.
Publicado: (2022)

Comparative COVID-19 Vaccine Effectiveness Over Time in Veterans
por: Mayr, Florian B, et al.
Publicado: (2022)

Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010–2020
por: Zhang, Audrey D., et al.
Publicado: (2021)

Assessment of Administration and Receipt of COVID-19 Vaccines by Race and Ethnicity in US Federally Qualified Health Centers
por: Cole, Megan B., et al.
Publicado: (2022)

Persistent drop in confidence following US recommended pause of Ad26.COV2.S vaccine administration
por: Rader, Benjamin, et al.
Publicado: (2023)

Endogenous Retroviruses: With Us and against Us
por: Meyer, Thomas J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_549gtei9fvos3t23u86snffq6l